Pharmacolog one step closer to bedside measurement of antibiotic levels

The Academic Hospital has today submitted its final report to Vinnova regarding a project that was run in collaboration with Pharmacolog AB. The aim of the project is to develop a bedside method for determining antibiotic concentration in blood.

The Vinnova project “Bedside measurement of blood plasma antibiotic levels in patients with severe infections” has been run by Uppsala University Hospital together with Pharmacolog AB. The project stated in September 2018 and has now been completed and final report has been sent to Vinnova. The project is part of Vinnova’s national program Medtech4Health. The Academic Hospital states in its report that within the framework of the project they have succeeded in developing methods for sample management and that the clinical prototype developed by Pharmacolog can detect antibiotic overdose, but the precision needs to be improved to detect underdosing.

Torbjörn Norberg, Product Manager and Head of Innovation comments: “It has been a very interesting project and we are very pleased with the good outcome. When treating patients with severe infections, it is crucial to achieve the correct concentration of antibiotics in the patient. Too low a concentration promotes the emergence of resistant bacteria and too high a concentration can be deadly for the patient. We intend to continue our collaboration with the Academic Hospital to further improve the performance of our prototype in order to be able to detect too low concentrations with greater precision.”

For more information contact:

Mats Högberg, CEO

Phone: +46
70-546 50 21

About Pharmacolog AB

Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through

Download as PDF

Send download link

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.